Stockscreener 앱 받기
0.8568
5.33%
-0.0482
시간 외 거래:
.91
0.0532
+6.21%
전일 마감가:
$0.905
열려 있는:
$0.89
하루 거래량:
158.33K
Relative Volume:
1.43
시가총액:
$37.88M
수익:
$15.97M
순이익/손실:
$-24.40M
주가수익비율:
-1.1296
EPS:
-0.7585
순현금흐름:
$-45.82M
1주 성능:
-7.87%
1개월 성능:
-12.54%
6개월 성능:
-18.40%
1년 성능:
-57.79%
1일 변동 폭
$0.81
$0.91
1주일 범위
$0.81
$0.9907
52주 변동 폭
$0.50
$2.50
Elutia Inc Stock (ELUT) Company Profile
명칭
Elutia Inc
전화
240-247-1143
주소
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.8568 | 42.46M | 15.97M | -24.40M | -45.82M | -0.7585 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 개시 | Cowen | Outperform |
| 2020-11-02 | 개시 | Piper Sandler | Overweight |
| 2020-11-02 | 개시 | Truist | Buy |
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia Inc (ELUT) Institutional Confidence - TradingKey
Elutia Inc (ELUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Elutia Inc (ELUT) Cash Flow - TradingKey
Elutia Inc (ELUT) Balance Sheet - TradingKey
Elutia Inc (ELUT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elutia Inc (ELUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elutia Inc (ELUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
ELUT|Elutia Inc|Price:0.930|Chg%:-0.003 - TradingKey
Elutia Inc (ELUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elutia, Inc. Revenue Breakdown – NASDAQ:ELUT - TradingView
Elutia, Inc. Revenue Breakdown – BOATS:ELUT - TradingView
Elutia Inc (ELUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elutia Sells SimpliDerm Business for Up to $11M to Fund NXT-41x Launch in $1.5B Plastic Surgery Market 1 - Minichart
Elutia Divests SimpliDerm Assets to Refocus Strategy - TipRanks
Lake Street Reaffirms Their Buy Rating on Elutia (ELUT) - The Globe and Mail
Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity - Benzinga
Elutia Agrees to Sell SimpliDerm for Up to $11 Million - marketscreener.com
Elutia to sell SimpliDerm business for up to $11 million - Investing.com
Elutia (ELUT) Finalizes Sale of SimpliDerm Business for Up to $1 - GuruFocus
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio - The Manila Times
Cellution Biologics Inc. Signs Definitive Agreement to - GlobeNewswire
Elutia Signs Definitive Agreement to Sell SimpliDerm® in - GlobeNewswire
Elutia Inc. (ELUT) Holds Steady Near Support as Uptrend Faces ResistanceGrowth Stock Picks - dars.gov.et
Cellution Biologics Llc agreed to acquire SimpliDerm human acellular dermal matrix business of Elutia Inc. for $11 million. - marketscreener.com
Elutia Inc. (ELUT) Q1 2026 Earnings: EPS Misses Estimates Amid Strategic ProgressProfit Recovery Report - dars.gov.et
Elutia Inc. (ELUT) Bounces From Support, Tests Key Resistance at $1.01RVOL Breakout - dars.gov.et
Elutia (ELUT) Q1 2026 Earnings: EPS Miss Weighs on Sentiment Amid Ongoing RestructuringDividend Cut Risk - DonanımHaber
Elutia Inc.(NasdaqCM: ELUT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Elutia Inc.(NasdaqCM: ELUT) added to Russell 3000E Growth Benchmark - marketscreener.com
Elutia Inc Class A Actuals & Estimates (NASDAQ:ELUT) - TradingView
Enterprise value to EBITDA forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to sales forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
ELUT Forecast — Price Target — Prediction for 2027 - TradingView
Elutia Holds Near Key $1 Level After Marginal DeclineGolden Cross - dars.gov.et
Enterprise value to revenue forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to book forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to earnings forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Enterprise value to EBIT forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Form 4 Elutia Inc For: 22 June By Investing.com - Investing.com South Africa
Elutia (ELUT) CEO reports RSU vesting and tax withholding, boosting share holdings - Stock Titan
Elutia Inc (ELUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Elutia Inc (ELUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ELUT: Drug-eluting biologic for breast reconstruction targets high infection rates in a $1.5B market - TradingView
Elutia Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesBanking Earnings Report - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock ReactionCost Structure Review - dars.gov.et
Elutia Inc. (NASDAQ: ELUT) Files 8-K with Updated Company Information and Key SEC Details – June 2026 - Minichart
Elutia shareholders approve board proposals at annual meeting - Investing.com
Elutia shareholders approve board proposals at annual meeting By Investing.com - Investing.com India
Elutia Shareholders Approve Amended Incentive Plan and Governance - TipRanks
Elutia (ELUT) investors approve equity plan amendment and annual say-on-pay - Stock Titan
Elutia Inc (ELUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Elutia Inc 주식 (ELUT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| NEELS GUIDO J | Director |
Jan 30 '26 |
Buy |
1.04 |
20,000 |
20,800 |
118,750 |
| NEELS GUIDO J | Director |
Jan 29 '26 |
Buy |
1.06 |
15,000 |
15,900 |
98,750 |
| NEELS GUIDO J | Director |
Jan 28 '26 |
Buy |
1.06 |
15,000 |
15,900 |
83,750 |
1.04%
11.95%
자본화:
|
볼륨(24시간):